EUVIMEDEUVIMED entdecken
Crossref

Safety and Efficacy of Percutaneous Morton Neuroma Cryoneurolysis Under Ultrasound Guidance

Benjamin Moulin, Giorgio Angelopoulos, Jean Luc Sarrazin, Stephane Romano, Olivier Vignaux, Thierry Guenoun, Massimiliano Di Primio, Antoine Hakime

CardioVascular and Interventional Radiology · 2024-06 · 47 (6) · 795-800

DOI: 10.1007/s00270-024-03669-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, online erschienen am 04.03.2024. Verfasst von Benjamin Moulin und 7 weiteren Autor:innen. Beteiligte Einrichtung: From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From…. Hauptthemen laut MEDLINE: Ultrasonography, Interventional, Cryosurgery, Morton Neuroma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To assess the technical success, safety and early efficacy of Morton neuroma (MN) cryoneurolysis. MATERIALS AND METHODS: Retrospective review of 54 consecutive patients with MN treated with cryoneurolysis after failure of conservative treatment, from September 2022 to June 2023. Outcomes measurements included technical success (defined a successful ultrasound-guided placement of the cryoprobe), procedural safety according to Cirse classification and change in 6 months post-procedure by pain numeric rating scale (pNRS). RESULTS: A total of 59 MN were treated during 55 procedures. Mean procedure duration was 47 min, all patients were discharged 2 h after the intervention. Technical success was 98.1%. No Cirse grade 3, 4 or 5 complication was reported. Three grade 2 complication occurred, including two chilblain-type lesions and one bone insufficiency fracture. At 6 months post-procedure, pNRS score was significantly decreased (2.7 ± 2.2 vs 7.1 ± 1.1) (p < 0.0001), with a mean score decrease of 4.1points. Thirty-two patients (60.4%) reported a complete pain relief, 15 (28.3%) a partial pain relief and 6 (11.3%) no pain relief, or increased pain. CONCLUSION: Cryoneurolysis seems to be safe for the treatment of Morton neuroma. Six-month pain relief is promising and needs to be confirmed at long term.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ultrasonography, InterventionalCryosurgeryMorton NeuromaHumansFemaleMaleRetrospective StudiesMiddle AgedAdultAgedTreatment OutcomePain Measurement

Stichwörter der Autor:innen

CryoneurolysisMetatarsalgiaMorton neuromaUltrasound guidance

Autor:innen und Institutionen

  • From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From the Anesthesiology Department (TG), American Hospital of Paris, 55 Bo…

Zitieren

APA

Moulin, B., Angelopoulos, G., Sarrazin, J. L., Romano, S., Vignaux, O., Guenoun, T., Di Primio, M., & Hakime, A. (2024). Safety and Efficacy of Percutaneous Morton Neuroma Cryoneurolysis Under Ultrasound Guidance. CardioVascular and Interventional Radiology, 47(6), 795-800. https://doi.org/10.1007/s00270-024-03669-1

Vancouver

Moulin B, Angelopoulos G, Sarrazin JL, Romano S, Vignaux O, Guenoun T, et al. Safety and Efficacy of Percutaneous Morton Neuroma Cryoneurolysis Under Ultrasound Guidance. CardioVascular and Interventional Radiology. 2024;47(6):795-800. doi:10.1007/s00270-024-03669-1

BibTeX
@article{Moulin2024,
  author = {Moulin, Benjamin and Angelopoulos, Giorgio and Sarrazin, Jean Luc and Romano, Stephane and Vignaux, Olivier and Guenoun, Thierry and Di Primio, Massimiliano and Hakime, Antoine},
  title = {Safety and Efficacy of Percutaneous Morton Neuroma Cryoneurolysis Under Ultrasound Guidance},
  journal = {CardioVascular and Interventional Radiology},
  year = {2024},
  volume = {47},
  number = {6},
  pages = {795--800},
  doi = {10.1007/s00270-024-03669-1}
}
Kostenlos starten →